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Objective: To investigate whether change in objective signs during up-titration of 
angiotensin-converting enzyme (ACE)-inhibitors in patients with chronic heart failure affect 
perception of information about medicines and subjective activities such as self-care.
Methods: Consecutive patients referred for up-titration of ACE-inhibitors were included. 
Patients were given the Satisfaction with Information about Medicines Scale and the European 
Heart Failure Self-Care Behaviour Scale at their ﬁ  rst visit and when the target dose was reached. 
Blood pressure, pulse and s-creatinine were measured at each visit.
Results: Relationships were found between change in systolic (r = 0.224, p = 0.044) and diastolic 
(r = 0.361, p = 0.001) blood pressure and change in self-care scores and were also observed 
at baseline (r = 0.324, 0.398, p = 0.001, 0.000) and follow-up (r = 0.317, 0.253, p = 0.004, 
0.022). Diastolic blood pressure correlated with the “potential problem of medication” score 
(r = −0.263, p = 0.007).
Conclusion: Patients with a more advanced disease usually have a lower blood pressure. Hence, 
the relationship between blood pressure and self-care scores might indicate that patients are 
more motivated to adhere to prescriptions the more advanced the stage of their disease.
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Introduction
Chronic heart failure (CHF) is a major health problem in the Western world. Despite 
considerable advances in treatment to increase survival, CHF is still associated with a 
high rate of hospitalization and mortality,1 with a 5-year survival reported to be about 
50%.2 Although the incidence of CHF is decreasing.1 An aging population, improved 
pharmacological treatment of CHF and decreased mortality in acute myocardial infarc-
tion are suggested to be underlying causes of a numerous amount of patients with CHF 
in the future.3 Not only does CHF have a substantial impact on the lives of patients 
because of a reduced quality of life, but also directly on the national health economy.4 
Severe symptoms such as fatigue and dyspnea affect the physical ability of the patients.5 
Nonadherence to medication, poor diet, and lack of monitoring of symptoms has 
been identiﬁ  ed as contributing to the vast majority of CHF-related hospitalization.6 
Patient education that involves motivating patients to commit to a course of therapy 
is an important component of management and outcome.7 However, many patients 
with CHF are unaware of the relation between symptoms and their condition and its 
treatment.8 The development of CHF clinics, most of which are nurse-directed, has 
expanded in industrialized countries. These clinics have been successful in improv-
ing knowledge, self-care behavior, quality of life, survival, adherence to therapeutic 
regimen and decreasing the hospitalization rate.9,10 The causative factors of these 
improvements, however, are unclear.11Vascular Health and Risk Management 2009:5 14
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In order to offer patients with CHF the best management, 
communication between professionals and patients should be 
optimized and the reasons why some patients do not incor-
porate or ask for information should be clariﬁ  ed.
In a recent report, patients’ understanding of their diag-
nosis of CHF was found to be independent of age, gender or 
cognitive functioning.12 Yet, as far as we know, no study has 
scrutinized the concordance between patients’ blood pressure 
and their satisfaction with information they are given about 
medication and self-care.
The aim of this study was therefore to investigate whether 
adhering to a complex medication regimen that inﬂ  uences 
blood pressure affects the patients’ perception of information 
given about medication, as well as to evaluate its impact on 
self-care.
Approval to conduct this study was obtained from the 
Research Ethics Board at Göteborg University and partici-
pants gave their written, informed consent to participate in 
the study.
Methods
Patients
Consecutive patients with chronic heart failure or asymptom-
atic left ventricular dysfunction (n = 124) were referred to two 
nurse-led outpatient heart failure clinics for up-titration of 
angiotensin-converting enzyme (ACE)-inhibitors (Table 1). 
During their visit to the clinic, the patients received informa-
tion about their medication regimes. Of these 124 patients, 
109 completed the Satisfaction with Information about 
Medicines Scale (SIMS)13 at their ﬁ  rst visit and then again 
when the maintenance or goal dose was reached. During the 
period of up-titration of medication, the patients visited one 
of two outpatient clinics, where they talked with specially 
trained nurses on an individual level about their medica-
tion. Both written information and verbal reinforcement 
were given concerning what the medicines were for, their 
effects, interactions and side effects. The patients were 
encouraged to talk about their perception of the medication 
(eg, the medication’s effectiveness). Finally, questions that 
the patients raised concerning the medication were individu-
ally addressed.
One hundred eight of these patients also completed the 
European Heart Failure Self-Care Behaviour Scale14 at base-
line and at follow-up.
The patients were divided into two groups: patients with 
blood pressure above 140/90 mmHg (hypertensive group) 
and below 140/90 mmHg (normotensive group). This is 
the limit between high-normal and grade 1 hypertension 
according to the deﬁ  nition and classiﬁ  cation of blood pres-
sure levels.16
The instruments
The SIMS is a 17-item instrument designed to assess the 
extent to which patients feel they have received sufﬁ  cient 
information about prescribed medication. The amount of 
information received is asked to be rated using the following 
response scale: “too much”, “about right”, “too little”, “none 
received”, “none needed”. Responses indicating dissatis-
faction (“too much”, “too little”, or “none received”) are 
scored 0, while the other responses indicating satisfaction 
with information (“about right” or “none needed”) were given 
a score of 1. The items are derived from the published rec-
ommendations of the British Pharmaceutical Industry for the 
type of information that patients require in order to facilitate 
the self-management of medication. Each item refers to a par-
ticular aspect of the prescribed medicines. Examples include 
“How to use your medicine” and “What you should do if you 
experience side effects”. The items can be summed up as a 
total satisfaction rating (TSR) and in two subscale scores: 
Action and usage of medication and potential problems of 
medication (PPM). Permission to use SIMS was received 
from the author (Prof. Robert Horne, University of Brighton, 
UK). The English version of the SIMS was translated into 
Swedish using a back-translation procedure.15
The European Heart Failure Self-Care Behaviour Scale is 
a 12-item, self-administered questionnaire that covers items 
Table 1 Up-titration of angiotensin-converting enzyme-inhibitors according to local guidelines
 Captopril Enalapril Ramipril/Lisinopril Cilazapril
Week 1 6.25 mg × 2 Day 1–3: 2.5 mg × 1 Day 1–3: 1.25 mg × 1 0.5 mg × 1
Day 4–7: 2.5 mg × 2 Day 4–7: 1.25 mg × 2
Week 2 6.25 mg × 3 5 mg × 2 2.5 mg × 2 1 mg × 1
Week 3 12.5 mg × 2 5 mg × 3 5 mg × 2 2 mg × 1
Week 4 12.5 mg × 3 10 mg × 2 2.5 mg × 1
Week 5 25 mg × 2Vascular Health and Risk Management 2009:5 15
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concerning self-care behaviour of patients with heart failure.14 
Examples include “I weigh myself every day” and “I eat a 
low salt diet”. The scale is used as a total scale and is scored 
from 1 to 5, where 1 = I completely agree and 5 = I do not 
agree at all. A total score is calculated by adding the ratings 
(from one to ﬁ  ve) on each of the 12 items. If more than three 
items are missing, a total score cannot be obtained. In case 
of less than three missing items the three are used to replace 
the missing score per item.
Statistical analysis
All analyses were conducted using the SPSS Advanced Sta-
tistics for Windows statistical package, version 12.0 (SPSS 
Inc., Chicago, IL, USA). Descriptive analysis was used to 
determine mean scores and sample characteristics. Analysis 
of differences in patients’ clinical characteristics between 
baseline and follow-up was conducted using the t-test for 
dependent means. To test the relationship the bivariate 
correlate was used. Linear regression was used to estimate 
confounding factors. P-values below 0.05 were considered 
as statistically signiﬁ  cant.
Results
We included 124 consecutive patients (27% were women) 
with a mean age of 70 years (SD = 11). The major cause of 
CHF was ischemic heart disease. Patient characteristics are 
given in Table 2. Most patients were treated with diuretics 
and beta-blockers (66, and 67%, respectively). A detailed 
description of the patients’ medicines is shown in Table 2. 
About 70% of the patients were classiﬁ  ed as NYHA II or III 
at baseline (Table 3). Both diastolic blood pressure and pulse 
decreased signiﬁ  cantly from the ﬁ  rst to the last visit (Table 3). 
However, there was no signiﬁ  cant change in systolic blood 
pressure (Table 3).
Table 4 shows the relationship between differences in 
the self-care and SIMS scores, and differences in blood pres-
sure, pulse and creatinine between baseline and follow-up. 
An association between self-care and systolic (p = 0.044) 
and diastolic (p = 0.001) blood pressure was noted, where 
an improvement in self-care was related to a decrease 
in blood pressure. No signiﬁ  cant association was found 
between delta pulse and creatinine and delta self-care and 
SIMS scores.
The relationships between blood pressure, pulse, creati-
nine and self-care and SIMS scores at baseline and follow-up 
are presented in Table 5. There was a signiﬁ  cant relation-
ship between systolic and diastolic blood pressure and 
self-care at both baseline (p = 0.001, 0.000) and follow-up 
( p = 0.004, 0.022). More speciﬁ  cally, lower blood pressure 
was correlated to better self-care. A signiﬁ  cant relationship 
was found between SIMS scores (satisfaction regarding 
medication, particularly potential problems associated with 
medical use) and diastolic blood pressure (p = 0.01 for TSR 
and 0.07 for PPM). The only signiﬁ  cant association between 
clinical characteristics and self-care and SIMS scores in 
the hypertensive group was between “satisfaction about 
action and usage of medication” and systolic blood pressure 
(p = 0.043) at baseline, where lower systolic blood pressure 
was associated with higher satisfaction with respect to medi-
cal information. At baseline relationships were found in the 
normotensive group between diastolic blood pressure and 
self-care (p = 0.001), total satisfaction rating (p = 0.007) 
and potential problems associated with taking medication 
(p = 0.006), ie, lower diastolic blood pressure was related 
to better self-care and higher satisfaction concerning the 
medical information patients received (Table 6). No signiﬁ  -
cant relationship was observed between blood pressure and 
SIMS scores in the normotensive group at follow-up, but 
there was a signiﬁ  cant relationship between self-care and 
Table 2 General characteristics of the patients
Characteristic  Patients  %
Age (years)   70 ± 11  
Gender Male (n) 88 71
 Female  (n) 33 27
Etiology Ischemic heart disease (n) 67 54
 Hypertension  (n) 25 22
  Valvular heart disease (n) 14 11
 Arrhythmia  (n) 13 10
  Dilated cardiomyopathy (n) 11 9
 Others  (n) 7 6
Concomitant 
diseases
Diabetes (n) 
Hypertension (n)
23
30
19
27
  Pulmonary disease (n) 16 14
Medication at 
baseline
Diuretics (n) 82 66
  Beta-receptor blockers (n) 83 67
 Lipid-lowering  drugs  (n) 37 30
 Spironolactone  (n) 22 18
 ASA  (n) 59 48
 Calciumantagonist  (n) 5 4
 Nitrates  (n) 15 12
 Digitalis  (n) 23 19
 Anticoagulantia  (n) 27 22
Abbreviation: ASA, acetyl salicylic acid.Vascular Health and Risk Management 2009:5 16
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systolic (p = 0.021) and diastolic (p = 0.042) blood pressure 
(Table 6).
In linear regression models adjusted for age, sex and 
NYHA-class, no statistically signiﬁ  cant confounding factors 
were found interfering with the change in systolic blood 
pressure.
Discussion
Our initial hypothesis was that by initiating treatment and 
up-titrating ACE-inhibitors, the blood pressure decreased to 
such an extent that the circulation of the brain is inﬂ  uenced 
and therefore the perception and self-care is changed. But 
on the contrary, in this study two interesting ﬁ  ndings are 
illustrated: the association between patients improved self-
care and decreasing blood pressure and patient satisfaction 
with information about medicines (SIMS) with decreasing 
diastolic blood pressure.
One reasonable interpretation of these results is that 
because the medicines (up-titrated ACE-inhibitors) are 
blood-pressure-lowering drugs, the association between 
decreasing diastolic blood pressure (delta BP) and improved 
self-care is associated with higher adherence to medication, 
the consequence of which is decreasing blood pressure. 
But, already at baseline (Table 5), ie, before the introduc-
tion of an ACE-inhibitor, we found that the lower the blood 
pressure, the better the self-care and the lower the diastolic 
blood pressure the better the SIMS. These relations prob-
ably occur because other medicines used in the treatment of 
CHF (eg, diuretics and beta-blockers) also decrease blood 
pressure when patients adhere to all medicines. Lower 
systolic and diastolic blood pressure and renal dysfunction 
are associated with higher mortality.17,18 Consequently, one 
might speculate whether the associations between lower 
blood pressure and better self-care and higher satisfaction 
Table 3 Clinical characteristics and medication of the patients
Characteristic  Baseline Follow-up p
Systolic BP (mmHg)   130 ± 21 128 ± 21 0.33
Diastolic BP (mmHg)   75 ± 12 71 ± 11 0.001
Pulse (heart rate/ minute)   72 ± 13 68 ± 11 0.004
Creatinine (μmol/L)   114 ± 21 117 ± 26 0.092
NYHA class, n (%): I 20 (16) 26 (21)  
  II 61 (49) 49 (40)  
  III 27 (22) 16 (13)  
 IV 1  (1) 0   
 Mean 2 ± 0.7 1.9 ± 0.7 0.001
Diuretics, n (%)   82 (66) 74 (60) NS
Spironolactone, n (%)   22 (18) 16 (13) NS
Beta receptor blockers, n (%)   83 (67) 82 (66) 0.083
Note: Data are mean ± SD if not otherwise stated.
Abbreviations: BP, blood pressure; NYHA, New York Heart Association.
Table 4 Relationships between change in clinical characteristics and change in self-care scores and total satisfaction rating
   Δ Self-care Δ delta TSR
Δ systolic BP Pearson correlation, r 0.224 −0.116
 p 0.044 0.297
Δ diastolic BP Pearson correlation, r 0.361 −0.216
 p 0.001 0.05
Δ Pulse Pearson correlation, r −0.043 −0.037
 p 0.705 0.741
Δ Creatinine Pearson correlation, r 0.011 −0.066
 p 0.926 0.552
Abbreviations: BP, blood pressure; TSR, total satisfaction rating.Vascular Health and Risk Management 2009:5 17
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with medical information indicate that patients might have 
been more motivated to assimilate and follow prescribed 
treatment the more serious and advanced the stage of their 
disease. One must therefore consider that the associations 
observed in this study might be that the nurses were more or 
less fervent in their education of the patient, depending on 
the clinical signs observed.
A study from 2003 that sheds light on the management 
of heart failure in primary care shows that general practi-
tioners have worries about using blood pressure lowering 
drugs in patients with CHF who often are elderly and frail.19 
However, the results of our study, might suggest that these 
worries are needless.
Patient education with its impact on adherence is probably 
an important factor in management and outcome of CHF.7 
However, many patients with CHF do not seem to be aware 
of the importance of following prescribed treatment, as well 
as recognizing signs and symptoms of deterioration of their 
condition.8,11 As recently shown by Granger and colleauges, 
patients’ need for information is still high even when the 
specialist nurses feel that the information given is sufﬁ  cient.20 
Hence, there must be factors contributing to this need for 
Table 5 Relationships between blood pressure and self-care and total satisfaction rating during baseline and follow-up
Self-care TSR PPM
Baseline Systolic BP Pearson correlation, r 0.324 −0.096 −0.131
p 0.001 0.328 0.182
Diastolic BP Pearson correlation, r 0.398 −0.250 −0.263
p 0.000 0.010 0.007
Follow-up Systolic BP Pearson correlation, r 0.317 −0.007 −0.036
p 0.004 0.950 0.747
Diastolic BP Pearson correlation, r 0.253 −0.048 −0.097
p 0.022 0.661 0.384
Notes: BP, blood pressure; TSR, total satisfaction rating; PPM, potential problems of medication.
Table 6 Relationships between blood pressure and self-care/total satisfaction rating in the normotensive and hypertensive groups at 
baseline and follow-up
Self-care TSR AUM PPM
Baseline:
BP   140/90 mmHg SBP Pearson corr, r 0.085 −0.113 −0.042 −0.147
p 0.452 0.316 0.708 0.189
DBP Pearson corr, r 0.318 −0.269 −0.188 −0.274
p 0.001 0.007 0.064 0.006
BP   140/90 mmHg SBP Pearson corr, r 0.121 −0.384 −0.416 −0.322
p 0.573 0.064 0.043 0.124
DBP Pearson corr, r 0.415 −0.080 0.007 −0.172
p 0.306 0.864 0.988 0.713
Follow-up:
BP   140/90 mmHg SBP Pearson corr, r 0.284 0.004 −0.052 0.009
p 0.021 0.974 0.673 0.941
DBP Pearson corr, r 0.229 −0.090 −0.088 −0.112
p 0.042 0.423 0.430 0.326
BP   140/90 mmHg SBP Pearson corr, r −0.016 0.129 0.153 0.093
p 0.954 0.622 0.557 0.731
DBP Pearson corr, r 0.984 −0.693 −0.500 −0.756
p 0.115 0.512 0.667 0.454
Abbreviations: BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; Pearson Corr, Pearson correlation; TSR, total satisfaction rating; AUM, action 
and usage of medication; PPM, potential problems of medication.Vascular Health and Risk Management 2009:5 18
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more information that we are not aware of. One plausible 
explanation is that nurses still rely on their perceptions of 
what they believe patients need to know rather than on what 
the patients actually feel would be important information. An 
example of this possibility is the patients wish to know more 
about how long to take the medication, whereas caregivers 
probably take it for granted that the patients are aware of 
the fact that the treatment is lifelong.20 The World Health 
Organization (WHO) strongly states in their Global Report 
on Innovative Care for Chronic Conditions: Building Blocks 
for Action (2002) that noncompliance is “fundamentally a 
failure of the health care system”.21 Compliance is deﬁ  ned 
by WHO as “the extent to which a person’s behavior- taking 
medication, following a diet, and/or executing lifestyle 
changes corresponds with agreed recommendations from 
a provider”.21 This deﬁ  nition emphasizes the contractual 
relationship between the caregiver and the patient: by 
agreeing with a recommendation, the patient enters into an 
active partnership with the provider in which the patient’s 
autonomous goals, such as the patient’s need for control, 
independence and choice, are acknowledged within the 
realm of the medical goals.22 To compensate for the provider-
centered image that the term compliance implies, alternative 
terms (eg, adherence, concordance, motivation to follow a 
therapy and self-care) have been proposed.23 To offer patients 
with CHF an active partnership (ie, concordance with the 
provider) future studies should focus on discovering those 
factors affecting communication between the patient and the 
caregiver in clinical practice. More attention should be paid 
to the association between clinical characteristics, subjective 
health and patients’ self-care and their perception of infor-
mation given to them about medication.24 Nonadherence is 
often not about patients disobeying or forgetting and thus 
cannot be solved solely with pharmacological information. 
Rather, the problem has to be approached by trying to under-
stand the patients’ way of thinking and adapt to their way 
of understanding. New approaches are being evaluated for 
the care and treatment of patients with CHF: models tailor 
the intervention from a patient’s subjective reports about his 
or her condition. The latter approach underscores the need 
of health providers to explore the relationship between a 
patient’s particular expression of distress and physiological 
disorder.
An important task for future researchers is to evaluate 
innovative pedagogical strategies based on an equal part-
nership between patients and caregivers. Such studies 
may contribute to improvement and development in CHF 
management.
Limitations
One limitation of this study is the rather small number of 
patients (n = 124).
Conclusion
Patients might be more motivated to assimilate and follow 
prescribed treatment the more serious and advanced the stage 
of their disease. More attention should be paid in providing 
good communication and information sharing to patients with 
mild to moderate CHF who should be even more actively 
encouraged to be involved in a partnership concerning the 
treatment of their condition.
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